Citation Impact
Citing Papers
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
2008
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
ASPM Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma
2008
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
1999
Basal cell carcinomas: attack of the hedgehog
2008 Standout
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
2011
GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes
2008
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
2000 Standout
Hepatocellular carcinoma
2003 Standout
CD44 in Cancer
2002
CD44: From adhesion molecules to signalling regulators
2003 Standout
Dysregulation of growth factor signaling in human hepatocellular carcinoma
2006
Molecular pathogenesis of human hepatocellular carcinoma
2002
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
2012 Standout
Toxic environmental exposures and kidney health in children
2015
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
2016 StandoutNobel
Clinical translation of angiogenesis inhibitors
2002 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
SOCS proteins, cytokine signalling and immune regulation
2007 Standout
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
2011
Interleukin-12 and the regulation of innate resistance and adaptive immunity
2003 Standout
Beta‐catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E‐cadherin and accumulation of p53, but not with expression of conventional WNT‐1 target genes
2003
Wnt signaling in cancer
2016 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
β-catenin mediates glandular formation and dysregulation of β-catenin induces hyperplasia formation in the murine uterus
2008
Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF‐β dependent fashion
2006
The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA
2015
Focus on hepatocellular carcinoma
2004
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Gestational trophoblastic disease
2010 Standout
Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma
2005
Otto Warburg's contributions to current concepts of cancer metabolism
2011 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Hepatocellular carcinoma
2012 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Hepatitis B virus infection
2009 Standout
High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutations
2004
Mutation of p53 gene in regenerative nodules in cirrhotic liver
2002
A survival–stratification model of human colorectal carcinomas with β‐catenin and p27kip1
2002
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations
2008 StandoutNobel
Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review
2012 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Structurally related antitumor effects of flavanones in vitro and in vivo: involvement of caspase 3 activation, p21 gene expression, and reactive oxygen species production
2004
CD44 and CD44v6 downregulation in clinical prostatic carcinoma: Relation to Gleason grade and cytoarchitecture
1998
Extracellular matrix structure
2015 Standout
Special Techniques for Imaging Blood Flow to Tumors
2002
Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma
2003
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
2007 Standout
De novo expression of CD44 variants in sporadic and hereditary gastric cancer
2010
Compliance with handwashing and barrier precautions
1995
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
Genetics of hepatocellular tumors
2006
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Epstein–Barr virus: 40 years on
2004 Standout
Detection of Epstein-Barr Virus in Invasive Breast Cancers
1999
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Genetic mechanisms of hepatocarcinogenesis
2002
Exploiting the hallmarks of cancer
2003
Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
2008
Overexpression of Orphan G–Protein-Coupled Receptor, Gpr49 , in Human Hepatocellular Carcinomas With β–Catenin Mutations
2003
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma
2010
Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination
2004
Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomas
2006
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Nanoparticle and targeted systems for cancer therapy
2004 Standout
Herpes Zoster
2013 Standout
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
2011
Organ‐specific profiles of genetic changes in cancers caused by activation‐induced cytidine deaminase expression
2008 StandoutNobel
Genomics and Signaling Pathways in Hepatocellular Carcinoma
2007
Identification of stem cells in small intestine and colon by marker gene Lgr5
2007 StandoutNature
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
2015
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Biological effects of essential oils – A review
2007 Standout
A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
2013
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
2003
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Importance of P-Cadherin, β-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma
2005
Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations.
2001
Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance
2016 StandoutNobel
Glutamine Synthetase Immunostaining Correlates with Pathologic Features of Hepatocellular Carcinoma and Better Survival after Radiofrequency Thermal Ablation
2010
Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors.
2002
Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
2012
Overexpression and Amplification of Aurora-A in Hepatocellular Carcinoma
2004
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice
2004
Mutations in mouse Aspm (abnormal spindle-like microcephaly associated) cause not only microcephaly but also major defects in the germline
2010 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
Expression of CD44 in premalignant and malignant Barrett's oesophagus
1998
Role of zinc-finger anti-viral protein in host defense against Sindbis virus
2015
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
2011
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Jan‐Show Chu being referenced
Loss of p53 and MCT-1 Overexpression Synergistically Promote Chromosome Instability and Tumorigenicity
2009
Characterization of the expression and activation of the epidermal growth factor receptor in squamous cell carcinoma of the skin
2006
p53 point mutation enhanced by hepatic regeneration in aflatoxin B1-induced rat liver tumors and preneoplastic lesions
1998
In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53‐associated cell cycle arrest
2003
The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities
2012
β-Catenin Mutations Are Associated with a Subset of Low-Stage Hepatocellular Carcinoma Negative for Hepatitis B Virus and with Favorable Prognosis
2000
The prognostic significance of tumor angiogenesis in Taiwanese patients with invasive ductal breast carcinomas
1998
Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma
1999
Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of the breast in Taiwan
1998
The possible use of colour flow Doppler in planning treatment in early invasive carcinoma of the cervix
1999
Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1α, GLUT1, and CAIX
2010
Expression of mutant nuclear β-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis
2001
Aberrant expression of cell‐cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability
2002
Minimal role of GB virus‐C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan
1999
Breast cancer angiogenesis: A quantitative morphologic and doppler imaging study
1995
Expression of CD44 and Its Clinical Implication in Diffuse–Type and Intestinal–Type Gastric Adenocarcinomas
1995
In situ detection of Epstein–Barr virus in breast cancer
1998
Senior medical studentsʼ knowledge of universal precautions
1993
Effect of Urinary Total Arsenic Level and Estimated Glomerular Filtration Rate on the Risk of Renal Cell Carcinoma in a Low Arsenic Exposure Area
2011
Expressions of E-Cadherin and Exon V6-Containing Isoforms of CD44 and their Prognostic Values in Human Transitional Cell Carcinoma
1995
MCPIP1 Suppresses Hepatitis C Virus Replication and Negatively Regulates Virus-Induced Proinflammatory Cytokine Responses
2014